| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |